When we hear about blood pressure, it's often in the context of hypertension — the "silent killer" that increases long-term risk for heart attacks and strokes. But there’s another side to the story ...

1.3 million patients are hospitalized annually in the U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for ...

Decreases seen in mortality for acute MI, ischemic heart disease, while increases seen for mortality from other heart disease subtypes ...

Bayer's mineralocorticoid receptor antagonist (MRA) Kerendia hit the mark as a treatment for a common form of heart failure in the FINEARTS-HF study, setting up regulatory approvals, but there is ...

Moderna is already riding high on the strength of its mRNA-based COVID-19 vaccine, but the broader potential of its technology has been shown in a new AstraZeneca-partnered candidate for heart ...

Heart transplantation remains the optimal long-term treatment for appropriate patients with advanced heart failure. However, the donor heart shortage is a limiting factor, and the risk profile of ...

Heart Failure : Heart Failure Center of Excellence includes the latest research, Medscape TV, cases, quizzes, and peer discussion of heart failure, in collaboration with the American College of ...